Engineered Minimal Type I CRISPR-Cas System for Transcriptional Activation and Base Editing in Human Cells

Type I CRISPR-Cas systems are widespread and have exhibited high versatility and efficiency in genome editing and gene regulation in prokaryotes. However, due to the multi-subunit composition and large size, their application in eukaryotes has not been thoroughly investigated. Here, we demonstrate that the type I-F2 Cascade, the most compact among type I systems, with a total gene size smaller than that of SpCas9, can be developed for transcriptional activation in human cells. The efficiency of the engineered I-F2 tool can match or surpass that of dCas9. Additionally, we create a base editor using the I-F2 Cascade, which induces a considerably wide editing window (~30 nt) with a bimodal distribution. It can expand targetable sites, which is useful for disrupting functional sequences and genetic screening. This research underscores the application of compact type I systems in eukaryotes, particularly in the development of a base editor with a wide editing window. Type I CRISPR-Cas systems are widely distributed in prokaryotes but have long been overlooked for applications in eukaryotes. Here, authors develop transcriptional activators and base editors with wide editing windows (~30 nt) in human cells using compact type I-F2 Cascades